Balyasny Asset Management’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-20,182	Closed	-$203K	–	2543
2023 Q4	$203K	Buy	+20,182	New	+$203K	﹤0.01%	1752
2022 Q4	–	Sell	-24,646	Closed	-$79K	–	2854
2022 Q3	$79K	Buy	+24,646	New	+$79K	﹤0.01%	1943